The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, T. J.
Right arrow Articles by Rothstein, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, T. J.
Right arrow Articles by Rothstein, T. L.

The Journal of Immunology, Vol 159, Issue 10 4834-4839, Copyright © 1997 by American Association of Immunologists


ARTICLES

Bcl-x protects primary B cells against Fas-mediated apoptosis

TJ Schneider, D Grillot, LC Foote, GE Nunez and TL Rothstein
Department of Microbiology, Boston University Medical Center, MA 02118, USA.

Primary murine splenic B cells are rendered sensitive or resistant to Fas-mediated apoptosis in a receptor-specific fashion. B cells stimulated though CD40 are Fas sensitive unless they also receive a signal though surface Ig that produces a state of resistance to Fas killing. Protection from Fas-mediated apoptosis takes time to develop and requires ongoing macromolecular synthesis; therefore, it appears to involve the induction and accumulation of one or more gene products. The role of Bcl-x was evaluated by examining the expression and function of this gene in primary B cells. bcl-x mRNA was induced by anti-IgM treatment of otherwise sensitive (CD40 ligand-treated) B cells. Bcl-x protein expression was induced by anti-IgM and appeared in a time frame that correlates well with the onset of anti-IgM-induced Fas resistance. Further, B cells from Bcl-x Tg mice were found to be resistant to Fas-mediated apoptosis. These results strongly suggest that the protection against Fas killing afforded by cross-linking surface Ig is mediated, at least in part, by an increase in Bcl-x.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. R. Dye, A. Palvanov, B. Guo, and T. L. Rothstein
B Cell Receptor Cross-Talk: Exposure to Lipopolysaccharide Induces an Alternate Pathway for B Cell Receptor-Induced ERK Phosphorylation and NF-{kappa}B Activation
J. Immunol., July 1, 2007; 179(1): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. I. Kuraishy, S. W. French, M. Sherman, M. Herling, D. Jones, R. Wall, and M. A. Teitell
TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation
PNAS, June 12, 2007; 104(24): 10175 - 10180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Guo, D. Blair, T. C. Chiles, C. A. Lowell, and T. L. Rothstein
Cutting Edge: B Cell Receptor (BCR) Cross-Talk: The IL-4-Induced Alternate Pathway for BCR Signaling Operates in Parallel with the Classical Pathway, Is Sensitive to Rottlerin, and Depends on Lyn
J. Immunol., April 15, 2007; 178(8): 4726 - 4730.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Frances, J. R. Tumang, and T. L. Rothstein
Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells
Int. Immunol., January 1, 2007; 19(1): 59 - 65.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. R. Shen, D. O. Ferguson, M. Renard, K. K. Hoyer, U. Kim, X. Hao, F. W. Alt, R. G. Roeder, H. C. Morse III, and M. A. Teitell
Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation
Blood, September 15, 2006; 108(6): 1991 - 1998.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Barrington, M. Zhang, X. Zhong, H. Jonsson, N. Holodick, A. Cherukuri, S. K. Pierce, T. L. Rothstein, and M. C. Carroll
CD21/CD19 Coreceptor Signaling Promotes B Cell Survival during Primary Immune Responses
J. Immunol., September 1, 2005; 175(5): 2859 - 2867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Frances, J. R. Tumang, and T. L. Rothstein
Cutting Edge: B-1 Cells Are Deficient in Lck: Defective B Cell Receptor Signal Transduction in B-1 Cells Occurs in the Absence of Elevated Lck Expression
J. Immunol., July 1, 2005; 175(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Guo and T. L. Rothstein
B Cell Receptor (BCR) Cross-Talk: IL-4 Creates an Alternate Pathway for BCR-Induced ERK Activation That Is Phosphatidylinositol 3-Kinase Independent
J. Immunol., May 1, 2005; 174(9): 5375 - 5381.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Tumang, R. Frances, S. G. Yeo, and T. L. Rothstein
Cutting Edge: Spontaneously Ig-Secreting B-1 Cells Violate the Accepted Paradigm for Expression of Differentiation-Associated Transcription Factors
J. Immunol., March 15, 2005; 174(6): 3173 - 3177.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. A. Mongini, A. E. Jackson, S. Tolani, R. J. Fattah, and J. K. Inman
Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis
J. Immunol., November 15, 2003; 171(10): 5244 - 5254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Zazzeroni, S. Papa, A. Algeciras-Schimnich, K. Alvarez, T. Melis, C. Bubici, N. Majewski, N. Hay, E. De Smaele, M. E. Peter, et al.
Gadd45{beta} mediates the protective effects of CD40 costimulation against Fas-induced apoptosis
Blood, November 1, 2003; 102(9): 3270 - 3279.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Romieu-Mourez, D. W. Kim, S. M. Shin, E. G. Demicco, E. Landesman-Bollag, D. C. Seldin, R. D. Cardiff, and G. E. Sonenshein
Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors
Mol. Cell. Biol., August 15, 2003; 23(16): 5738 - 5754.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. R Balkundi, J. A Ziegler, J. F Watchko, C. Craven, and M. Trucco
Regulation of FasL/Fas in Human Trophoblasts: Possible Implications for Chorioamnionitis
Biol Reprod, August 1, 2003; 69(2): 718 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Mizuno and T. L. Rothstein
Cutting Edge: CD40 Engagement Eliminates the Need for Bruton's Tyrosine Kinase in B Cell Receptor Signaling for NF-{kappa}B
J. Immunol., March 15, 2003; 170(6): 2806 - 2810.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Schram and T. L. Rothstein
NF-{kappa}B Is Required for Surface Ig-Induced Fas Resistance in B Cells
J. Immunol., March 15, 2003; 170(6): 3118 - 3124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Wurster, V. L. Rodgers, M. F. White, T. L. Rothstein, and M. J. Grusby
Interleukin-4-mediated Protection of Primary B Cells from Apoptosis through Stat6-dependent Up-regulation of Bcl-xL
J. Biol. Chem., July 19, 2002; 277(30): 27169 - 27175.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Tumang, R. S. Negm, L. A. Solt, T. J. Schneider, T. P. Colarusso, W. D. Hastings, R. T. Woodland, and T. L. Rothstein
BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton's Tyrosine Kinase
J. Immunol., March 15, 2002; 168(6): 2712 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. M. Oshiro, T. H. Landowski, R. Catlett-Falcone, L. A. Hazlehurst, M. Huang, R. Jove, and W. S. Dalton
Inhibition of JAK Kinase Activity Enhances Fas-mediated Apoptosis but Reduces Cytotoxic Activity of Topoisomerase II Inhibitors in U266 Myeloma Cells
Clin. Cancer Res., December 1, 2001; 7(12): 4262 - 4271.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Owyang, J. R. Tumang, B. R. Schram, C. Y. Hsia, T. W. Behrens, T. L. Rothstein, and H.-C. Liou
c-Rel Is Required for the Protection of B Cells from Antigen Receptor-Mediated, But Not Fas-Mediated, Apoptosis
J. Immunol., November 1, 2001; 167(9): 4948 - 4956.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. M. Catlett, P. Xie, B. S. Hostager, and G. A. Bishop
Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis
J. Immunol., May 15, 2001; 166(10): 6019 - 6024.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Yoshikawa, Y. Nakajima, and K. Tasaka
Enhanced Expression of Fas-Associated Death Domain-Like IL-1-Converting Enzyme (FLICE)-Inhibitory Protein Induces Resistance to Fas-Mediated Apoptosis in Activated Mast Cells
J. Immunol., December 1, 2000; 165(11): 6262 - 6269.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. F. Yeatman , II, S. M. Jacobs-Helber, P. Mirmonsef, S. R. Gillespie, L. A. Bouton, H. A. Collins, S. T. Sawyer, C. P. Shelburne, and J. J. Ryan
Combined Stimulation with the T Helper Cell Type 2 Cytokines Interleukin (IL)-4 and IL-10 Induces Mouse Mast Cell Apoptosis
J. Exp. Med., October 9, 2000; 192(8): 1093 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hennino, M. Berard, M. Casamayor-Palleja, P. H. Krammer, and T. Defrance
Regulation of the Fas Death Pathway by FLICE-Inhibitory Protein in Primary Human B Cells
J. Immunol., September 15, 2000; 165(6): 3023 - 3030.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Massari, Y. Ho, and L. M. Wetzler
Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis
PNAS, August 1, 2000; 97(16): 9070 - 9075.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Majlessi and G. Bordenave
Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2ab-producing B cells
Int. Immunol., July 1, 2000; 12(7): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Chen, L. C. Edelstein, and C. Gélinas
The Rel/NF-kappa B Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL
Mol. Cell. Biol., April 15, 2000; 20(8): 2687 - 2695.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. Yin, L. Zhang, R. Wang, L. Radvanyi, C. Haudenschild, Q. Fang, M. R. Kehry, and Y. Shi
Ligation of CD28 In Vivo Induces CD40 Ligand Expression and Promotes B Cell Survival
J. Immunol., October 15, 1999; 163(8): 4328 - 4334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. M. Catlett and G. A. Bishop
Cutting Edge: A Novel Mechanism for Rescue of B Cells from CD95/Fas-Mediated Apoptosis
J. Immunol., September 1, 1999; 163(5): 2378 - 2381.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Tuscano, A. Riva, S. N. Toscano, T. F. Tedder, and J. H. Kehrl
CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade
Blood, August 15, 1999; 94(4): 1382 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. H. Lee, H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng
NF-kappa B-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
PNAS, August 3, 1999; 96(16): 9136 - 9141.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. J. Schneider, G. M. Fischer, T. J. Donohoe, T. P. Colarusso, and T. L. Rothstein
A Novel Gene Coding for a Fas Apoptosis Inhibitory Molecule (FAIM) Isolated from Inducibly Fas-resistant B Lymphocytes
J. Exp. Med., March 15, 1999; 189(6): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. C. Shaw, W. Swat, R. Ferrini, L. Davidson, and F. W. Alt
Activated Ras Signals Developmental Progression of Recombinase-activating Gene (RAG)-deficient Pro-B Lymphocytes
J. Exp. Med., January 4, 1999; 189(1): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. C. Rathmell, S. Fournier, B. C. Weintraub, J. P. Allison, and C. C. Goodnow
Repression of B7.2 on Self-reactive B Cells Is Essential to Prevent Proliferation and Allow Fas-mediated Deletion by CD4+ T Cells
J. Exp. Med., August 17, 1998; 188(4): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. C. Foote, A. Marshak-Rothstein, and T. L. Rothstein
Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis after Treatment with Interleukin 4 but Not after Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold Is Exceeded
J. Exp. Med., March 16, 1998; 187(6): 847 - 853.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.